Position in LRMR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$907,201
-$2,422,538 QoQ
Shares Held
297,443
-59.8% QoQ
Ownership
0.286%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 162 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LRMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. LRMR ranks #181 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in LRMR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $907,201 | 297,443 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,329,739 | 739,942 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,132,583 | 297,266 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,773,413 | 858,642 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,623,434 | 561,742 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,096,187 | 974,971 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,987,407 | 513,542 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,317,665 | 353,842 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,017,979 | 278,342 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $3,821,124 | 503,442 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,124,041 | 247,042 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $969,100 | 245,342 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $881,326 | 281,574 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $827,821 | 182,742 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $944,836 | 228,774 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $948,374 | 296,367 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $344,062 | 175,542 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $699,605 | 172,742 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,080,031 | 192,774 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,839,539 | 246,274 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,922,500 | 195,774 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,104,245 | 212,474 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $4,739,617 | 221,374 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $3,019,952 | 199,074 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,680,175 | 208,574 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||